Registry of SVHC intentions until outcome

Registry of SVHC intentions until outcome

Registry of SVHC intentions until outcome

The registry of SVHC intentions until outcome aims to make interested parties aware of the substances for which an SVHC dossier is planned to be submitted to ECHA.

Member States, or ECHA at the request of the European Commission, may propose a substance to be identified as a substance of very high concern (SVHC) by preparing a dossier in accordance with the requirements set out in Annex XV to REACH.

Interested parties can follow the progress of a proposal through the SVHC identification process, from the notification of the intention until the outcome. The advance notice gives interested parties time to prepare for commenting later in the process.

Interested parties with relevant information on the identity or hazard properties of the substance may submit such information during the consultation.

Hexabromocyclododecane (HBCDD)

and all major diastereoisomers identified EC / List no: - CAS no: -
Further substance information
CLP Annex VI index number
Status
Identified SVHC
Date of intention
08-mag-2008
Expected date of submission
30-giu-2008
Submitted for accordance check
30-giu-2008
Withdrawal date
Submitter
Sweden
Remarks
Scope
PBT (Article 57d)
Start of consultation
30-giu-2008
End of consultation
14-ago-2008
Consultation document
RCOM (Comments received)
Year of MSC agreement
2008
MSC Agreement
Date of MSC agreement
08-ott-2008
Support documents
MSC Opinion
Date of MSC opinion
Minority position
Date of inclusion in Candidate List
28-ott-2008
First published
28-feb-2018

Help Help
Group members
This group of substance has the following member substances:
Results list is empty
Name EC / List no. CAS no. Association
1,2,5,6,9,10-hexabromocyclodecane 221-695-9 3194-55-6 Official source
gamma-hexabromocyclododecane 603-804-5 134237-52-8 Official source
Hexabromocyclododecane 247-148-4 25637-99-4 Official source
alpha-hexabromocyclododecane 603-801-9 134237-50-6 Official source
beta-hexabromocyclododecane 603-802-4 134237-51-7 Official source